Hulk, really nice post below and is exactly what is always in my mind lately about how hard the nerd revenge group of investors, shorts and all you mentioned that are after what we have in Leronlimab as it's the only drug that has practically no side effects and goes after the disease rather than what the big pharma companies do,they just try to stop the symptoms of diseases and their drugs have mostly horrible side effects that doctors have to prescribe other drugs to stop the bad effects of the original drugs they produce which in the end, they get to keep making the money machine pile up more and more money for them, it's a machine against man kind!
I too have not even sold 1 share since 2016 and I too won't but I will sell my cost of the original investment after our 1st of many approvals and hang on for the rest of the indications.
GLTU Hulk and thanks for posting that for it hurts what these groups of people are doing to our share price. I surely thought that $1.39 would hold from March of last year but it just blew that away at $1.36, UGH I need that pink stuff, Pepto-bismol, to calm my stomach down but I'll take what ever they throw at us and still won't sell as that's what they want us to do -
HCIT/ahab333
______________________________________________________
Hulk's post:
"i've been in for 6 years. read every article, watched every interview and listened to every call. my background is in finance (although this is my first foray into OTC land, which is a swamp - no offense to swamps).
everything in my gut tells me:
1. the science is absolutely rock-solid - and it will achieve approval in at least one massive market - which will propel the value to a large multiple of current value. the 13d group knows this - which is why they are pursuing this.
2. NP and Kelly (although they have flaws, like all of us) are working very hard, making progress, and are aligned with shareholders at this point. my view is that NP is on an absolute mission to see this through. i'll take grit over polish every time, as you can't always have both.
3. the team has learned from their mistakes - and those lessons have put us on target for some type of approval this year. i remind myself that this is how progress is ultimately made in any endeavor.
4. Picking up Recknor was a coup - he is a stud - and will carry the BLA across the goal line. I love his no-nonsense, "man of few words" approach.
i haven't sold any shares (which my wife likes to often remind me of, as she remembers it hitting $9). i have always said that i won't sell any shares until we get an approval, uplist, and are on the radar of Wall Street, BP, etc. I still expect all of that to happen - and it should coincide with a SP of greater than $10 (hopefully much greater)."
I too have not even sold 1 share since 2016 and I too won't but I will sell my cost of the original investment after our 1st of many approvals and hang on for the rest of the indications.
GLTU Hulk and thanks for posting that for it hurts what these groups of people are doing to our share price. I surely thought that $1.39 would hold from March of last year but it just blew that away at $1.36, UGH I need that pink stuff, Pepto-bismol, to calm my stomach down but I'll take what ever they throw at us and still won't sell as that's what they want us to do -
HCIT/ahab333
______________________________________________________
Hulk's post:
"i've been in for 6 years. read every article, watched every interview and listened to every call. my background is in finance (although this is my first foray into OTC land, which is a swamp - no offense to swamps).
everything in my gut tells me:
1. the science is absolutely rock-solid - and it will achieve approval in at least one massive market - which will propel the value to a large multiple of current value. the 13d group knows this - which is why they are pursuing this.
2. NP and Kelly (although they have flaws, like all of us) are working very hard, making progress, and are aligned with shareholders at this point. my view is that NP is on an absolute mission to see this through. i'll take grit over polish every time, as you can't always have both.
3. the team has learned from their mistakes - and those lessons have put us on target for some type of approval this year. i remind myself that this is how progress is ultimately made in any endeavor.
4. Picking up Recknor was a coup - he is a stud - and will carry the BLA across the goal line. I love his no-nonsense, "man of few words" approach.
i haven't sold any shares (which my wife likes to often remind me of, as she remembers it hitting $9). i have always said that i won't sell any shares until we get an approval, uplist, and are on the radar of Wall Street, BP, etc. I still expect all of that to happen - and it should coincide with a SP of greater than $10 (hopefully much greater)."
13
1
